These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 23296784)

  • 1. A molecular genetic approach to uncovering the differential functions of dopamine D2 receptor isoforms.
    Wang Y; Sasaoka T; Dang MT
    Methods Mol Biol; 2013; 964():181-200. PubMed ID: 23296784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor.
    Bulwa ZB; Sharlin JA; Clark PJ; Bhattacharya TK; Kilby CN; Wang Y; Rhodes JS
    Alcohol; 2011 Nov; 45(7):631-9. PubMed ID: 21803530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age and dopamine D2L receptor-deficiency on motor and learning functions.
    Fetsko LA; Xu R; Wang Y
    Neurobiol Aging; 2005 Apr; 26(4):521-30. PubMed ID: 15653180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different activation of NF-kappaB by stimulation of dopamine D2L and D2S receptors through calcineurin activation.
    Takeuchi Y; Fukunaga K
    J Neurochem; 2004 Jul; 90(1):155-63. PubMed ID: 15198675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells.
    Takeuchi Y; Fukunaga K
    J Neurochem; 2003 May; 85(4):1064-74. PubMed ID: 12716438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D2 receptor mutant mice.
    Chausmer AL; Elmer GI; Rubinstein M; Low MJ; Grandy DK; Katz JL
    Psychopharmacology (Berl); 2002 Aug; 163(1):54-61. PubMed ID: 12185400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D
    Shioda N; Imai Y; Yabuki Y; Sugimoto W; Yamaguchi K; Wang Y; Hikida T; Sasaoka T; Mieda M; Fukunaga K
    J Neurosci; 2019 Sep; 39(38):7551-7563. PubMed ID: 31371425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D2 receptor activates extracellular signal-regulated kinase through the specific region in the third cytoplasmic loop.
    Takeuchi Y; Fukunaga K
    J Neurochem; 2004 Jun; 89(6):1498-507. PubMed ID: 15189353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes.
    Colelli V; Fiorenza MT; Conversi D; Orsini C; Cabib S
    Genes Brain Behav; 2010 Oct; 9(7):703-11. PubMed ID: 20546314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor D2 deficiency reduces mouse pup ultrasonic vocalizations and maternal responsiveness.
    Curry T; Egeto P; Wang H; Podnos A; Wasserman D; Yeomans J
    Genes Brain Behav; 2013 Jun; 12(4):397-404. PubMed ID: 23521753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of brain activity between dopamine D2 receptor-knockout and wild mice in response to dopamine agonist and antagonist assessed by fMRI.
    Kuriwaki J; Nishijo H; Kondoh T; Uwano T; Torii K; Katsuki M; Ono T
    Neurosignals; 2004; 13(5):227-40. PubMed ID: 15305090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse.
    Huang F; Yan T; Shi F; An J; Xie R; Zheng F; Li Y; Chen J; Qu J; Zhou X
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5537-44. PubMed ID: 25097246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: proteins interacting with the third cytoplasmic loop of dopamine D2 and D3 receptors.
    Shioda N; Takeuchi Y; Fukunaga K
    J Pharmacol Sci; 2010; 114(1):25-31. PubMed ID: 20716856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D
    Shioda N
    J Pharmacol Sci; 2017 Oct; ():. PubMed ID: 29107444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.
    Le Foll B; Diaz J; Sokoloff P
    Life Sci; 2005 Jan; 76(11):1281-96. PubMed ID: 15642598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
    Sánchez-Soto M; Bonifazi A; Cai NS; Ellenberger MP; Newman AH; Ferré S; Yano H
    Mol Pharmacol; 2016 Apr; 89(4):457-66. PubMed ID: 26843180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional response in dopamine D2L receptor-deficient mice.
    Hranilovic D; Bucan M; Wang Y
    Behav Brain Res; 2008 Dec; 195(2):246-50. PubMed ID: 18835570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
    Centonze D; Gubellini P; Usiello A; Rossi S; Tscherter A; Bracci E; Erbs E; Tognazzi N; Bernardi G; Pisani A; Calabresi P; Borrelli E
    Neuroscience; 2004; 129(1):157-66. PubMed ID: 15489038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.